HGF and MET: From Brain Development to Neurological Disorders

Area of Science:

• Neuroscience
• Developmental Biology
• Molecular Biology

Background:

• Hepatocyte growth factor (HGF) and its receptor MET are crucial for nervous system development and function.
• These molecules are involved in neuronal growth, survival, and synaptogenesis from prenatal stages through adulthood.

Purpose of the Study:

• To review the multifaceted roles of HGF-MET signaling in neurodevelopment and neurological disorders.
• To explore the connection between MET deregulation and conditions like autism spectrum disorder (ASD).
• To discuss the therapeutic potential of HGF and its mimetics for neurodegenerative diseases and injuries.

Main Methods:

• Literature review of existing research on HGF-MET signaling in the nervous system.
• Analysis of preclinical models for neurodegenerative diseases and injuries.
• Examination of studies linking MET expression to developmental disorders.

Main Results:

• HGF-MET signaling is essential for synaptogenesis during post-natal brain development.
• MET deregulation is associated with developmental disorders, including ASD.
• HGF demonstrates neuroprotective effects in models of Alzheimer's disease, ALS, MS, spinal cord injury, and cerebral ischemia.
• HGF promotes neuronal survival via pro-angiogenic, anti-inflammatory, and immune-modulatory mechanisms.
• HGF stimulates neural stem cells, enhancing neuroregeneration.

Conclusions:

• HGF-MET signaling has diverse roles in neural development, function, and repair.
• Targeting HGF-MET pathways offers promising therapeutic strategies for a range of neurological conditions.
• Further research into HGF mimetics could lead to novel treatments for neurodegenerative diseases and brain injuries.